Inhibition of GSDMD activation by Z-LLSD-FMK or Z-YVAD-FMK reduces vascular inflammation and atherosclerotic lesion development in ApoE-/- mice.
Front Pharmacol
; 14: 1184588, 2023.
Article
in En
| MEDLINE
| ID: mdl-37593179
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland